Blue Owl Capital Holdings »

Global Technology Acquisit A shares owned by Blue Owl Capital Holdings

Quarter-by-quarter ownership of Global Technology Acquisit A (GTACW) shares owned by Blue Owl Capital Holdings from 13F filings

Historical chart of Blue Owl Capital Holdings investment in Global Technology Acquisit A

Tip: Access up to 7 years of quarterly data

All positions including Global Technology Acquisit A held by Blue Owl Capital Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Global Technology Acquisit A by Blue Owl Capital Holdings

Quarter filed Position value Share count Share price at filing
2024-09-30 $7.5k 150k 0.05

More positions owned by Blue Owl Capital Holdings

Nuveen Churchill Direct Lend Com Shs (NCDL)
Klaviyo Com Ser A (KVYO)
Tourmaline Bio (TRML)
Pliant Therapeutics (PLRX)
Cullinan Oncology (CGEM)
Owl Rock Capital Corporation (OBDC)
Larimar Therapeutics (LRMR)
Proshares Tr Ultrapro Qqq (TQQQ)
Engene Holdings (ENGN)
Evercommerce (EVCM)
Acelyrin (SLRN)
Conduent Incorporate (CNDT)
Repare Therapeutics Ord (RPTX)
Context Therapeutics (CNTX)
Ultragenyx Pharmaceutical (RARE)

View all positions for Blue Owl Capital Holdings

Top funds holding Global Technology Acquisit A

683 Capital Management
Shaolin Capital Management
Maverick Capital
Highbridge Capital Management
OZ Management
Cowen And Company
Picton Mahoney Asset Management
Wolverine Asset Management
Context Capital Management
Verition Fund Management
Polar Securities
Atalaya Capital Management
Blue Owl Capital Holdings
Aristeia Capital
Saba Capital Management

View all funds holding Global Technology Acquisit A